Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.

Authors :: Houot R
Bachy E
Cartron G
Gros FX
Morschhauser F
Oberic L
Gastinne T
Feugier P
Duléry R
Thieblemont C
Joris M
Jardin F
Choquet S
Casasnovas O
Brisou G
Cheminant M
Bay JO
Gutierrez FL
Menard C
Tarte K
Delfau MH
Portugues C
Itti E
Palard-Novello X
Blanc-Durand P
Al Tabaa Y
Bailly C
Laurent C
Lemonnier F
Source :: Nature medicine [Nat Med] 2023 Oct; Vol. 29 (10), pp. 2665.
Publication Year :: 2023

Full Text Access

Tools